Effects and underlying mechanisms of human opiorphin on cardiovascular activity in anesthetized rats
Authors:
- 1 February 2015
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 749, 32-38
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Hainan Province, China (312023)
- National Natural Science Foundation of China, China (31400430)
- Scientific Technology Research Projects of Gansu Province (1104NKCA092)
This publication has 25 references indexed in Scilit:
- Opiorphin increases blood pressure of conscious rats through renin-angiotensin system (RAS)Peptides, 2014
- Cardiovascular effects of intravenous administered 26RFa, a novel RFamide peptide ligand for GPR103, in anaesthetised ratsEuropean Journal of Pharmacology, 2009
- Sitagliptin Augments Sympathetic Enhancement of the Renovascular Effects of Angiotensin II in Genetic HypertensionHypertension, 2008
- Aminopeptidase N in arterial hypertensionHeart Failure Reviews, 2007
- Sialorphin (the mature peptide product of Vcsa1 ) relaxes corporal smooth muscle tissue and increases erectile function in the ageing ratBJU International, 2006
- Synthesis and effects of active fragments of angiotensin IIKidney International, 1997
- Angiotensin II-mediated catecholamine release during the pressor response in ratsJournal of Endocrinology, 1994
- Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension.Hypertension, 1992
- Intracerebroventricularly applied peptidase inhibitors increase endogenous angiotensin levelsBrain Research, 1990
- Increased blood pressure induced by central application of aminopeptidase inhibitors is angiotensinergic-dependent in normotensive and hypertensive rat strainsBrain Research, 1989